223 related articles for article (PubMed ID: 16286124)
1. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
Bassett WW; Cooperberg MR; Sadetsky N; Silva S; DuChane J; Pasta DJ; Chan JM; Anast JW; Carroll PR; Kane CJ
Urology; 2005 Nov; 66(5):1060-5. PubMed ID: 16286124
[TBL] [Abstract][Full Text] [Related]
2. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database.
Grossfeld GD; Chang JJ; Broering JM; Miller DP; Yu J; Flanders SC; Henning JM; Stier DM; Carroll PR
J Urol; 2000 Apr; 163(4):1171-7; quiz 1295. PubMed ID: 10737489
[TBL] [Abstract][Full Text] [Related]
3. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC
Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
[TBL] [Abstract][Full Text] [Related]
4. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
5. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.
Motamedinia P; Korets R; Spencer BA; Benson MC; McKiernan JM
Urology; 2008 Nov; 72(5):1106-10. PubMed ID: 18602142
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database.
Macdonald OK; D'Amico AV; Sadetsky N; Shrieve DC; Carroll PR
Urology; 2007 Jul; 70(1):106-10. PubMed ID: 17656218
[TBL] [Abstract][Full Text] [Related]
8. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
[TBL] [Abstract][Full Text] [Related]
9. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
[TBL] [Abstract][Full Text] [Related]
10. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
Stroup SP; Cullen J; Auge BK; L'Esperance JO; Kang SK
Cancer; 2007 Sep; 110(5):1003-9. PubMed ID: 17614338
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
Bastian PJ; Palapattu GS; Yegnasubramanian S; Lin X; Rogers CG; Mangold LA; Trock B; Eisenberger M; Partin AW; Nelson WG
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5361-7. PubMed ID: 17875764
[TBL] [Abstract][Full Text] [Related]
12. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
Yokomizo A; Murai M; Baba S; Ogawa O; Tsukamoto T; Niwakawa M; Tobisu K; Kinukawa N; Naito S
BJU Int; 2006 Sep; 98(3):549-53. PubMed ID: 16925752
[TBL] [Abstract][Full Text] [Related]
13. Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.
van Roermund JG; Kok DE; Wildhagen MF; Kiemeney LA; Struik F; Sloot S; van Oort IM; Hulsbergen-van de Kaa CA; van Leenders GJ; Bangma CH; Witjes JA
BJU Int; 2009 Aug; 104(3):321-5. PubMed ID: 19220264
[TBL] [Abstract][Full Text] [Related]
14. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
[TBL] [Abstract][Full Text] [Related]
15. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
[TBL] [Abstract][Full Text] [Related]
16. Interval from prostate biopsy to radical prostatectomy: effect on PSA, Gleason sum, and risk of recurrence.
Shibata A; Mohanasundaram UM; Terris MK
Urology; 2005 Oct; 66(4):808-13. PubMed ID: 16230143
[TBL] [Abstract][Full Text] [Related]
17. Should we replace the Gleason score with the amount of high-grade prostate cancer?
Vis AN; Roemeling S; Kranse R; Schröder FH; van der Kwast TH
Eur Urol; 2007 Apr; 51(4):931-9. PubMed ID: 16935413
[TBL] [Abstract][Full Text] [Related]
18. Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.
Chung CS; Chen MH; Cullen J; McLeod D; Carroll P; D'Amico AV
Urology; 2008 Jan; 71(1):136-40. PubMed ID: 18242382
[TBL] [Abstract][Full Text] [Related]
19. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.
Kane CJ; Bassett WW; Sadetsky N; Silva S; Wallace K; Pasta DJ; Cooperberg MR; Chan JM; Carroll PR
J Urol; 2005 Mar; 173(3):732-6. PubMed ID: 15711258
[TBL] [Abstract][Full Text] [Related]
20. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database.
Freedland SJ; Bañez LL; Sun LL; Fitzsimons NJ; Moul JW
Prostate Cancer Prostatic Dis; 2009; 12(3):259-63. PubMed ID: 19581922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
